Update on the phase 1/2 trial of BAX-335, an adeno-associated virus 8 (AAV8) vector-based gene therapy for program for hemophilia B - Monahan, P E; Walsh, C E; Powell, J S (J Thromb Haemost, 2015)
, et al.